Skip to main content
. 2023 Oct 12;17:1248922. doi: 10.3389/fncel.2023.1248922

Figure 3.

Figure 3

In vitro and in vivo protocols for generating SCs and investigating SC-neuron interaction. In vitro protocols use primary SCs, SC lines, SCs generated from direct reprogramming, or SCs derived from iPSCs. These in vitro protocols are used to investigate candidate therapeutic drugs and to study pathomechanisms of neuropathies (A). In vivo preclinical studies involve the use of animal models of neuropathies and peripheral nerve injuries. Currently, different therapies such as gene therapy and immunotherapies have been explored in preclinical trials (B).